MX2018007782A - Forma cristalina de gemcitabina. - Google Patents

Forma cristalina de gemcitabina.

Info

Publication number
MX2018007782A
MX2018007782A MX2018007782A MX2018007782A MX2018007782A MX 2018007782 A MX2018007782 A MX 2018007782A MX 2018007782 A MX2018007782 A MX 2018007782A MX 2018007782 A MX2018007782 A MX 2018007782A MX 2018007782 A MX2018007782 A MX 2018007782A
Authority
MX
Mexico
Prior art keywords
gemcitabine
crystalline form
alaninyl
benzoxy
phenyl
Prior art date
Application number
MX2018007782A
Other languages
English (en)
Inventor
Griffith Hugh
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Publication of MX2018007782A publication Critical patent/MX2018007782A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Esta invención se refiere a una forma cristalina de gemcitabina-[fenil-benzoxi-L-alaninil)]-(S)-fosfato.
MX2018007782A 2015-12-23 2016-12-21 Forma cristalina de gemcitabina. MX2018007782A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1522771.3A GB201522771D0 (en) 2015-12-23 2015-12-23 Crystalline form of a phosphate derivative
PCT/GB2016/054017 WO2017109485A1 (en) 2015-12-23 2016-12-21 Crystalline form of gemcitabine

Publications (1)

Publication Number Publication Date
MX2018007782A true MX2018007782A (es) 2018-08-15

Family

ID=55311540

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018007782A MX2018007782A (es) 2015-12-23 2016-12-21 Forma cristalina de gemcitabina.

Country Status (13)

Country Link
US (1) US11377467B2 (es)
EP (1) EP3394077A1 (es)
JP (1) JP6840151B2 (es)
KR (1) KR20180096685A (es)
CN (1) CN108699099A (es)
AU (1) AU2016375860B2 (es)
BR (1) BR112018012943A2 (es)
CA (1) CA3008556A1 (es)
GB (1) GB201522771D0 (es)
HK (1) HK1255112A1 (es)
MX (1) MX2018007782A (es)
SG (1) SG11201805061YA (es)
WO (1) WO2017109485A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10005810B2 (en) 2012-11-16 2018-06-26 University College Cardiff Consultants Limited Process for preparing nucleoside prodrugs
SI3119794T1 (en) 2014-06-25 2018-02-28 NuCana plc FORMULATION, COMPOSITION OF GEMCITABIN PREPARED
CN106459129B (zh) 2014-06-25 2020-03-31 努卡那有限公司 吉西他滨前药
GB201417644D0 (en) 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
US10660912B2 (en) 2015-10-05 2020-05-26 NuCana plc Combination therapy for cancer
PT3386998T (pt) 2015-12-11 2021-11-30 NuCana plc Síntese diastereosseletiva de derivados fosfato e do pró-fármaco gemcitabina nuc-10311
GB201522771D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Crystalline form of a phosphate derivative

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
FR2954310B1 (fr) 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
US10005810B2 (en) * 2012-11-16 2018-06-26 University College Cardiff Consultants Limited Process for preparing nucleoside prodrugs
WO2014204856A1 (en) 2013-06-17 2014-12-24 Catabasis Pharmaceuticals, Inc. Fatty acid anticancer derivatives and their uses
JP2017504572A (ja) 2013-11-27 2017-02-09 アイデニクス・ファーマシューティカルズ・エルエルシー 肝臓癌治療のためのヌクレオチド類
SI3119794T1 (en) 2014-06-25 2018-02-28 NuCana plc FORMULATION, COMPOSITION OF GEMCITABIN PREPARED
CN106459129B (zh) 2014-06-25 2020-03-31 努卡那有限公司 吉西他滨前药
EP3172218B1 (en) 2014-07-22 2020-10-21 NuCana plc Process for the preparation of gemcitabine-[phenyl(benzoxy-l-alaninyl)] phosphate
GB201417644D0 (en) * 2014-10-06 2014-11-19 Nucana Biomed Ltd Method of separating phosphate diastereoisomers
US9848863B2 (en) * 2015-02-25 2017-12-26 Globus Medical, Inc Surgical retractor systems and methods
KR20180021697A (ko) 2015-05-14 2018-03-05 뉴카나 피엘씨 암 치료
CN106543220A (zh) * 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 氨基磷酸酯化合物及其制备方法和晶体
CN106543252A (zh) * 2015-09-16 2017-03-29 博瑞生物医药（苏州）股份有限公司 核苷氨基磷酸酯类前药的制备方法及其中间体
CN112156102B (zh) * 2015-09-16 2023-10-03 济南高合医疗科技有限公司 一种nuc-1031单一异构体的晶型及其制备方法
US10660912B2 (en) 2015-10-05 2020-05-26 NuCana plc Combination therapy for cancer
PT3386998T (pt) 2015-12-11 2021-11-30 NuCana plc Síntese diastereosseletiva de derivados fosfato e do pró-fármaco gemcitabina nuc-10311
HUE050290T2 (hu) 2015-12-23 2020-11-30 NuCana plc Kombinált terápia
GB201522771D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Crystalline form of a phosphate derivative
KR102566461B1 (ko) 2015-12-23 2023-08-14 뉴카나 피엘씨 조합 요법
WO2018019188A1 (zh) 2016-07-23 2018-02-01 博瑞生物医药（苏州）股份有限公司 核苷氨基磷酸酯类前药的多晶型及其制备方法

Also Published As

Publication number Publication date
HK1255112A1 (zh) 2019-08-02
EP3394077A1 (en) 2018-10-31
BR112018012943A2 (pt) 2018-12-11
CA3008556A1 (en) 2017-06-29
AU2016375860B2 (en) 2021-06-03
US11377467B2 (en) 2022-07-05
JP6840151B2 (ja) 2021-03-10
SG11201805061YA (en) 2018-07-30
CN108699099A (zh) 2018-10-23
KR20180096685A (ko) 2018-08-29
GB201522771D0 (en) 2016-02-03
US20210188893A1 (en) 2021-06-24
JP2018538341A (ja) 2018-12-27
WO2017109485A1 (en) 2017-06-29
AU2016375860A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
MX2018007782A (es) Forma cristalina de gemcitabina.
HK1247726A1 (zh) 烟酰胺核苷的結晶形式
MX2018001300A (es) Profarmacos de analogos de glutamina.
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
EP3119795A4 (en) Gemcitabine analogs
IL258149B (en) Aggregate galnac phosphoramidite
MX2016011160A (es) Tratamiento de afecciones asociadas con la hiperinsulinemia.
GB201609601D0 (en) Phosphoramidate compounds
GB201405597D0 (en) Production of cryptographic signatures
GB201517844D0 (en) Binaural synthesis
HK1252936A1 (zh) 漂移賽車
PT3334734T (pt) Forma c de avibactam sódico
IL266087A (en) Use of itolizumab to reduce cd6 phosphorylation
IL273387A (en) Thylanstatin analogs
MX2017011389A (es) Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos.
EP3207034A4 (en) Anhydrous crystalline form of s-equol
MX2016014255A (es) Producto ceramico refractario.
MX2016012653A (es) Eteraminas basadas en dialcoholes.
GB2551839B (en) Improvements relating to footwear
GB2574946B (en) Binaural synthesis
IL274808A (en) Phosphoramidate diphosphate salts of nucleosides as anticancer compounds
IL271586B1 (en) Ibandronate conjugates of nucleotide antimetabolites
CY1123685T1 (el) Μεθοδος πεγκυλιωσης
GB201711193D0 (en) Novel prodrugs of acyclic nucleoside phosphonates
GB201704577D0 (en) Novel prodrugs of acyclic nucleoside phosphonates